Levacetylleucine (1 brand name, 1 dosage form, 1 route)
Available dosage forms: FOR SUSPENSION.
Routes of administration: ORAL.
Brand Names
- AQNEURSA
Indications and Usage
AQNEURSA™ is indicated for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing ≥15 kg.
Contraindications
None.
Mechanism of Action
The distinct molecular target for levacetylleucine in the treatment of NPC is unknown.
⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.